Skip to content

The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders

Pituitary Gonadotropin Response to GnRH Stimulation in Menstrual, Climacteric and, Menopause-Related Mood and Behavioral Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001232
Enrollment
140
Registered
2002-12-10
Start date
1988-07-31
Completion date
2000-06-30
Last updated
2008-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder, Healthy, Mental Disorders, Mood Disorders

Keywords

Depression, FSH, GnRH, LH, Menopause, Menstrual Cycle

Brief summary

The normal menstrual cycle is produced by a series of hormonal signals that starts with the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. The hypothalamus is located in the brain and is often referred to as the master gland. GnRH then acts on the pituitary gland and causes it to release two hormones, follicle stimulating hormone (FSH) and lutenizng hormone (LH). LH and FSH act on the ovary and cause it to release the hormones directly involved in menstruation, estrogen and progesterone. The purpose of this research study is to evaluate the hypothalamic-pituitary-gonadal axis activity as measured by pituitary hormones, FSH and LH in response to intravenous doses of gonadotropin releasing hormone (GnRH) in menstrual cycle-related hormones.

Detailed description

This protocol is designed to accompany clinical protocol #81-M-0126, The Phenomenology and Biophysiology of Menstrually Regulated Mood and Behavior Disorders, as well as the submitted protocol, The Phenomenology and Biophysiology of Climacteric and Menopause-Related Mood and Behavioral Disorders. Its purpose will be to evaluate hypothalamic-pituitary-gonadal axis regulation as measured by pituitary gonadotropin, i.e., follicle stimulating hormone (FSH) and luteinizing hormone (LH), response to intravenous administration of gonadotropin releasing hormone (GnRH) in menstrual cycle-related mood disorders.

Interventions

None listed

Sponsors

National Institute of Mental Health (NIMH)
Lead SponsorNIH

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

Age 18-65. Female. Use of barrier methods of birth control. Not pregnant. Not taking ongoing medications. No medical illnesses.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026